ALPS Medical Breakthroughs ETF
SBIO
47 hedge funds and large institutions have $48.6M invested in ALPS Medical Breakthroughs ETF in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 5 closing their positions.
1,014% more call options, than puts
Call options by funds: $2.4M | Put options by funds: $215K
78% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 9
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
1.82% more ownership
Funds ownership: 23.59% → 25.41% (+1.8%)
4% more capital invested
Capital invested by funds: $46.9M → $48.6M (+$1.71M)
0% more funds holding
Funds holding: 47 → 47 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$710K |
| 2 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$470K |
| 3 |
Jane Street
New York
|
+$423K |
| 4 |
Morgan Stanley
New York
|
+$362K |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
+$299K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$456K |
| 2 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$257K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$226K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$138K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$103K |
SBIO Hedge Fund Activity: Q2 2019 in Review
47 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q2 2019, worth a combined $48.6M — up 3.7% from $46.9M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new SBIO positions and 5 closed out — a net gain of 2 holders — while 16 added to existing stakes and 9 trimmed.
The largest buyer was Commonwealth Equity Services, adding an estimated $710K. The largest seller was Virtu Financial, exiting entirely with an estimated $456K sold.
- 47 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $48.6M of ALPS Medical Breakthroughs ETF stock for Q2 2019, up 3.7% quarter-over-quarter.
- 7 funds opened new ALPS Medical Breakthroughs ETF positions in Q2 2019 and 5 closed out, a net change of +2 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q2 2019 was Commonwealth Equity Services, an estimated $710K added.
- The largest ALPS Medical Breakthroughs ETF seller in Q2 2019 was Virtu Financial, an estimated $456K sold.
Based on aggregated 13F filings for Q2 2019.